First Time Loading...

Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 336.22 USD -0.19%
Updated: Apr 25, 2024

Intrinsic Value

Stryker Corp. engages in the provision of medical technology products and services. [ Read More ]

The intrinsic value of one SYK stock under the Base Case scenario is 265.29 USD. Compared to the current market price of 336.22 USD, Stryker Corp is Overvalued by 21%.

Key Points:
SYK Intrinsic Value
Base Case
265.29 USD
Overvaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Stryker Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SYK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Stryker Corp

Provide an overview of the primary business activities
of Stryker Corp.

What unique competitive advantages
does Stryker Corp hold over its rivals?

What risks and challenges
does Stryker Corp face in the near future?

Has there been any significant insider trading activity
in Stryker Corp recently?

Summarize the latest earnings call
of Stryker Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Stryker Corp.

Provide P/S
for Stryker Corp.

Provide P/E
for Stryker Corp.

Provide P/OCF
for Stryker Corp.

Provide P/FCFE
for Stryker Corp.

Provide P/B
for Stryker Corp.

Provide EV/S
for Stryker Corp.

Provide EV/GP
for Stryker Corp.

Provide EV/EBITDA
for Stryker Corp.

Provide EV/EBIT
for Stryker Corp.

Provide EV/OCF
for Stryker Corp.

Provide EV/FCFF
for Stryker Corp.

Provide EV/IC
for Stryker Corp.

Show me price targets
for Stryker Corp made by professional analysts.

What are the Revenue projections
for Stryker Corp?

How accurate were the past Revenue estimates
for Stryker Corp?

What are the Net Income projections
for Stryker Corp?

How accurate were the past Net Income estimates
for Stryker Corp?

What are the EPS projections
for Stryker Corp?

How accurate were the past EPS estimates
for Stryker Corp?

What are the EBIT projections
for Stryker Corp?

How accurate were the past EBIT estimates
for Stryker Corp?

Compare the revenue forecasts
for Stryker Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Stryker Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Stryker Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Stryker Corp compared to its peers.

Compare the P/E ratios
of Stryker Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Stryker Corp with its peers.

Analyze the financial leverage
of Stryker Corp compared to its main competitors.

Show all profitability ratios
for Stryker Corp.

Provide ROE
for Stryker Corp.

Provide ROA
for Stryker Corp.

Provide ROIC
for Stryker Corp.

Provide ROCE
for Stryker Corp.

Provide Gross Margin
for Stryker Corp.

Provide Operating Margin
for Stryker Corp.

Provide Net Margin
for Stryker Corp.

Provide FCF Margin
for Stryker Corp.

Show all solvency ratios
for Stryker Corp.

Provide D/E Ratio
for Stryker Corp.

Provide D/A Ratio
for Stryker Corp.

Provide Interest Coverage Ratio
for Stryker Corp.

Provide Altman Z-Score Ratio
for Stryker Corp.

Provide Quick Ratio
for Stryker Corp.

Provide Current Ratio
for Stryker Corp.

Provide Cash Ratio
for Stryker Corp.

What is the historical Revenue growth
over the last 5 years for Stryker Corp?

What is the historical Net Income growth
over the last 5 years for Stryker Corp?

What is the current Free Cash Flow
of Stryker Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Stryker Corp.

Financials

Balance Sheet Decomposition
Stryker Corp

Current Assets 12.5B
Cash & Short-Term Investments 3B
Receivables 3.8B
Other Current Assets 5.7B
Non-Current Assets 27.4B
PP&E 3.7B
Intangibles 19.8B
Other Non-Current Assets 3.8B
Current Liabilities 7.9B
Accounts Payable 1.5B
Accrued Liabilities 3.6B
Other Current Liabilities 2.8B
Non-Current Liabilities 13.4B
Long-Term Debt 10.9B
Other Non-Current Liabilities 2.5B
Efficiency

Earnings Waterfall
Stryker Corp

Revenue
20.5B USD
Cost of Revenue
-7.4B USD
Gross Profit
13.1B USD
Operating Expenses
-8.7B USD
Operating Income
4.4B USD
Other Expenses
-1.2B USD
Net Income
3.2B USD

Free Cash Flow Analysis
Stryker Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

SYK Profitability Score
Profitability Due Diligence

Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
62/100
Profitability
Score

Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

SYK Solvency Score
Solvency Due Diligence

Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
High Interest Coverage
Long-Term Solvency
64/100
Solvency
Score

Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SYK Price Targets Summary
Stryker Corp

Wall Street analysts forecast SYK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYK is 379.48 USD with a low forecast of 342.39 USD and a high forecast of 426.3 USD.

Lowest
Price Target
342.39 USD
2% Upside
Average
Price Target
379.48 USD
13% Upside
Highest
Price Target
426.3 USD
27% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SYK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SYK Price
Stryker Corp

1M 1M
-4%
6M 6M
+30%
1Y 1Y
+12%
3Y 3Y
+30%
5Y 5Y
+88%
10Y 10Y
+390%
Annual Price Range
336.22
52w Low
253.85
52w High
358.71
Price Metrics
Average Annual Return 8.64%
Standard Deviation of Annual Returns 10.57%
Max Drawdown -44%
Shares Statistics
Market Capitalization 126.9B USD
Shares Outstanding 383 900 000
Percentage of Shares Shorted 1.17%

SYK Return Decomposition
Main factors of price return

What is price return decomposition?

SYK News

Other Videos

Last Important Events
Stryker Corp

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Stryker Corp

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Stryker Corp Logo
Stryker Corp

Country

United States of America

Industry

Health Care

Market Cap

126.9B USD

Dividend Yield

0.96%

Description

Stryker Corp. engages in the provision of medical technology products and services. The company is headquartered in Portage, Michigan and currently employs 46,000 full-time employees. The firm offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.

Contact

MICHIGAN
Portage
2825 Airview Blvd
+12693892600.0
https://www.stryker.com/

IPO

1980-03-17

Employees

46 000

Officers

Chairman, CEO & President
Mr. Kevin A. Lobo
VP & CFO
Mr. Glenn S. Boehnlein
Group President of Global Quality & Operations
Mr. Viju S. Menon
Group President of MedSurg & Neurotechnology
Mr. J. Andrew Pierce
Group President of Orthopaedics & Spine
Mr. Spencer S. Stiles
VP & Chief Accounting Officer
Mr. William E. Berry Jr.
Show More
CTO and VP of Global R&D - Joint Replacement
Mr. Robert C. Cohen
VP, Chief Information Officer & Chief Information Security Officer
Mr. Alan Douville
Vice President of Investor Relations
Mr. Jason Beach
VP & Chief Legal Officer
Mr. Robert S. Fletcher
Show Less

See Also

Discover More
What is the Intrinsic Value of one SYK stock?

The intrinsic value of one SYK stock under the Base Case scenario is 265.29 USD.

Is SYK stock undervalued or overvalued?

Compared to the current market price of 336.22 USD, Stryker Corp is Overvalued by 21%.